Jamieson Wellness Inc (JWEL) AI Stock Analysis

• Market Cap: C$1.54B
• Dividend Yield: 2.27%
• Average Volume (3M): 66.62K
• Price to Earnings (P/E): 26.5
• Beta (1Y): 1.02
• Revenue Growth: 11.87%
• EPS Growth: 56.93%
• Country: CA
• Employees: 891
• Sector: Consumer Defensive
• Sector Strength: 69
• Industry: Packaged Foods
• EPS (TTM): 0.40
• Shares Outstanding: 41,770,897
• 10 Day Avg. Volume: 84,886
• 30 Day Avg. Volume: 66,624
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$42.59
• Price Target Upside: 15.51% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 7

• Rating: 77 Outperform
• Price Target: C$43.00 ▲(16.63% Upside)

Jamieson Wellness Inc. demonstrates strong financial performance and strategic growth, particularly in the Chinese market. While technical indicators suggest overbought conditions, the company's solid financial health and strategic initiatives support a positive outlook.

Positive Factors

Growth Opportunities

The U.S. and China markets present significant growth opportunities for Jamieson Wellness, supported by ongoing growth in Canada and International markets.

Revenue Targets

Jamieson Wellness is expected to reach its long-term revenue target of over $1 billion, driven mainly by the Jamieson Brands segment across all major geographies, supported by secular tailwinds.

Valuation

The valuation of Jamieson Wellness stock is compelling, trading at a lower multiple compared to the peer average and recent market takeovers.

Negative Factors

Revenue Performance

Revenue was slightly below forecast in Canada, but China was above forecast, showing strong growth.

Jamieson Wellness Inc Business Overview & Revenue Model

Company Description

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

How the Company Makes Money

Jamieson Wellness Inc makes money primarily through the sale of its vitamins, minerals, and supplements (VMS) products. Its revenue model is based on a combination of direct sales through retail partners and online platforms, as well as distribution agreements with key retailers and pharmacies. The company has a diversified portfolio of brands, including its flagship Jamieson brand, which contributes significantly to its revenue stream. Additionally, Jamieson Wellness engages in strategic partnerships and acquisitions to expand its product offerings and market reach. Factors such as product innovation, brand recognition, and a strong distribution network also play crucial roles in driving the company's earnings.

Jamieson Wellness Inc Financial Statement Overview

Summary

Jamieson Wellness Inc. exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet shows moderate leverage, but the overall financial health remains stable.

Income Statement

Jamieson Wellness Inc. demonstrates strong income statement performance with consistent revenue growth, evidenced by a TTM revenue increase. The gross profit margin has remained healthy, and net profit margins are stable, indicating effective cost management. The EBIT and EBITDA margins show solid operational efficiency, supporting profitability.

Balance Sheet

The company's balance sheet reflects moderate leverage with a reasonable debt-to-equity ratio, suggesting managed financial risk. The equity ratio indicates a solid proportion of assets funded by shareholders, enhancing financial stability. However, some caution is warranted due to the rise in total liabilities over the periods.

Cash Flow

Jamieson Wellness Inc. has shown robust cash flow performance with a significant increase in free cash flow, indicating strong cash generation capability. The operating cash flow to net income ratio is favorable, demonstrating efficient cash conversion. However, the company should monitor capital expenditures closely to sustain free cash flow growth.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	733.78M	676.17M	547.37M	451.03M	403.66M
Gross Profit	275.61M	233.56M	198.34M	162.44M	144.76M
EBITDA	114.60M	108.78M	100.17M	90.40M	75.30M
Net Income	51.91M	47.88M	52.81M	52.08M	41.60M
Balance Sheet
Total Assets	1.21B	1.14B	1.11B	652.48M	609.34M
Cash, Cash Equivalents and Short-Term Investments	44.79M	36.86M	26.24M	6.78M	1.17M
Total Debt	308.29M	462.99M	400.00M	149.13M	149.06M
Total Liabilities	660.41M	662.38M	675.67M	310.45M	316.94M
Stockholders Equity	505.18M	438.93M	431.59M	342.02M	292.40M
Cash Flow
Free Cash Flow	51.41M	22.41M	36.02M	22.12M	27.43M
Operating Cash Flow	61.58M	31.71M	50.59M	44.41M	40.60M
Investing Cash Flow	-10.16M	-35.13M	-256.53M	-22.28M	-13.17M
Financing Cash Flow	-45.43M	14.04M	225.41M	-16.51M	-26.46M

Jamieson Wellness Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 36.87
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Positive. The current price of 36.87 is above the 20-day moving average (MA) of 34.69, above the 50-day MA of 35.34, and above the 200-day MA of 33.53, indicating a bullish trend. The MACD of 0.22 indicates Negative momentum. The RSI at 67.14 is Neutral, neither overbought nor oversold. The STOCH value of 89.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JWEL.

Jamieson Wellness Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JWEL	77 Outperform	C$1.54B	26.53	12.75%	2.27%	11.87%	56.93%
Sector *	63 Neutral	$21.00B	13.77	-6.24%	3.09%	3.49%	-6.25%
DTEAF	―	$20.56M	―	-4.42%	―	―	―
BABYF	―	$4.94M	―	-351.09%	―	―	―
NPRFF	―	$6.44M	―		―	―	―
CULT	33 Underperform	C$1.40M	―	-185.93%	―	―	-82.60%
PNGA	27 Underperform	C$4.54M	―	-78.70%	―	-96.63%	32.78%

Jamieson Wellness Inc Corporate Events

Jamieson Wellness Inc. Reports Strong Q2 2025 Results with Significant Growth in China

Jamieson Wellness Inc. reported strong second quarter results for 2025, with a 13.8% increase in branded revenue, driven by successful marketing and promotional strategies across key markets. The company’s growth was highlighted by a 73% increase in its Chinese market due to the effective 6/18 program, alongside notable gains in Canada and the U.S. The results reflect Jamieson’s strategic execution and innovation in product offerings, which have bolstered its market position and operational performance, leading to increased dividends and a focus on global expansion.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness to Announce Q2 2025 Financial Results

Jamieson Wellness Inc. announced it will release its second quarter 2025 financial results on August 7, 2025, followed by a conference call for investors. This announcement is significant as it provides stakeholders an opportunity to gain insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Inc. Reports Successful Election of Directors at 2025 Shareholder Meeting

Jamieson Wellness Inc. announced the successful election of its nominee directors at the 2025 Annual Meeting of Shareholders, with all directors receiving overwhelming support. This development underscores the company’s stable governance and continued focus on expanding its market presence in the natural health industry.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Redeems Series A Preference Shares, Strengthens China Market Position

Jamieson Wellness Inc. announced the redemption of its Series A Preference Shares held by DCP Capital Partners, reflecting a strategic financial move aligned with DCP’s investment cycle. This redemption underscores the successful partnership between Jamieson and DCP, which has significantly bolstered Jamieson’s presence in China’s VMS market, contributing to substantial growth and positioning the company for continued success in this critical market.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.